10-103473464-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001129742.2(CALHM3):​c.784G>A​(p.Gly262Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 1,539,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

CALHM3
NM_001129742.2 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.727

Publications

0 publications found
Variant links:
Genes affected
CALHM3 (HGNC:23458): (calcium homeostasis modulator 3) Predicted to enable cation channel activity. Predicted to be involved in ATP transport. Predicted to be located in basolateral plasma membrane. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.046136975).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CALHM3NM_001129742.2 linkc.784G>A p.Gly262Ser missense_variant Exon 3 of 3 ENST00000369783.4 NP_001123214.1 Q86XJ0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CALHM3ENST00000369783.4 linkc.784G>A p.Gly262Ser missense_variant Exon 3 of 3 1 NM_001129742.2 ENSP00000358798.4 Q86XJ0

Frequencies

GnomAD3 genomes
AF:
0.0000201
AC:
3
AN:
149318
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000514
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000339
AC:
5
AN:
147608
AF XY:
0.0000382
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000827
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000937
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000178
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000151
AC:
21
AN:
1390586
Hom.:
0
Cov.:
34
AF XY:
0.0000219
AC XY:
15
AN XY:
685258
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30520
American (AMR)
AF:
0.0000857
AC:
3
AN:
35002
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24646
East Asian (EAS)
AF:
0.0000282
AC:
1
AN:
35434
South Asian (SAS)
AF:
0.0000512
AC:
4
AN:
78052
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48370
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5660
European-Non Finnish (NFE)
AF:
0.0000121
AC:
13
AN:
1075314
Other (OTH)
AF:
0.00
AC:
0
AN:
57588
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000201
AC:
3
AN:
149318
Hom.:
0
Cov.:
33
AF XY:
0.0000274
AC XY:
2
AN XY:
72910
show subpopulations
African (AFR)
AF:
0.0000514
AC:
2
AN:
38908
American (AMR)
AF:
0.00
AC:
0
AN:
15148
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5050
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000285
Hom.:
0
Bravo
AF:
0.0000340

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 04, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.784G>A (p.G262S) alteration is located in exon 3 (coding exon 3) of the CALHM3 gene. This alteration results from a G to A substitution at nucleotide position 784, causing the glycine (G) at amino acid position 262 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.5
DANN
Benign
0.53
DEOGEN2
Benign
0.0034
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.30
T
M_CAP
Benign
0.0077
T
MetaRNN
Benign
0.046
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.73
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
0.18
N
REVEL
Benign
0.014
Sift
Benign
0.47
T
Sift4G
Benign
0.90
T
Vest4
0.041
MVP
0.030
ClinPred
0.019
T
GERP RS
2.6
Varity_R
0.026
gMVP
0.19
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs986549915; hg19: chr10-105233221; API